MorphoSys Stock (NASDAQ: MOR) stock price, news, charts, stock research, profile.
Open | $18.59 |
Close | - |
Volume / Avg. | 60.18K / 300.60K |
Day Range | 18.48 - 18.70 |
52 Wk Range | 4.18 - 19.50 |
Market Cap | $2.82B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | - |
Days to Cover | 3.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MorphoSys (NASDAQ:MOR) through any online brokerage.
Other companies in MorphoSys’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and PTC Therapeutics (NASDAQ:PTCT).
There is no analysis for MorphoSys.
MorphoSys has a consensus price target of $8.08.
The stock price for MorphoSys (NASDAQ: MOR) is $18.08 last updated July 3, 2024 at 1:47 PM EDT.
There are no upcoming dividends for MorphoSys.
MorphoSys’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for MorphoSys.
MorphoSys is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.